Table 7 Pancancer and cancer-specific labels used for clinical label enrichment analysis. Pathological M, N and T labels refer to the TNM staging system, which describes the anatomical extent of tumor cancers [25]
From: Consensus clustering applied to multi-omics disease subtyping
Pan-cancer | Age at initial pathologic diagnosis, Gender, Pathologic M, Pathologic N, Pathologic T, Pathologic stage, Histological type, New neoplasm event type, Neoplasm histologic grade |
AML | CALGB cytogenetics risk category, FAB morphology code |
BIC | PAM50Call RNAseq, Estrogen receptor status, Progesterone receptor status, ER level cell percentage category, PR level cell percentage category |
COAD | Presence of colon polyps, History of colon polyps |
GBM | Prior glioma |
KIRC | Hemoglobin result, Platelet qualitative result, Serum calcium result, White cell count result |
LIHC | Adjacent hepatic tissue inflammation extent type, Albumin result specified value, Creatinine value, Fetoprotein outcome value, Fibrosis ishak score |
LUSC | Tobacco smoking history, Number pack years smoked |
OV | No supplementary clinical label |
SARC | No supplementary clinical label |
SKCM | Melanoma Clark level value, Melanoma ulceration indicator |